Kevin E. Weddington

Array ( [id] => 6830437 [patent_doc_number] => 20030181495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor' [patent_app_type] => new [patent_app_number] => 10/394794 [patent_app_country] => US [patent_app_date] => 2003-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21433 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181495.pdf [firstpage_image] =>[orig_patent_app_number] => 10394794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809485 [patent_doc_number] => 20030199424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Method of treatment and/or prophylaxis' [patent_app_type] => new [patent_app_number] => 10/393056 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 19613 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20030199424.pdf [firstpage_image] =>[orig_patent_app_number] => 10393056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6982950 [patent_doc_number] => 20050153020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Composition comprising phosphate' [patent_app_type] => utility [patent_app_number] => 10/507838 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8532 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153020.pdf [firstpage_image] =>[orig_patent_app_number] => 10507838 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7173433 [patent_doc_number] => 20050203186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Medicaments containing active ingredients which lower the level of cholesterol with time-delayed active ingredient release' [patent_app_type] => utility [patent_app_number] => 10/506583 [patent_app_country] => US [patent_app_date] => 2003-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6194 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203186.pdf [firstpage_image] =>[orig_patent_app_number] => 10506583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805494 [patent_doc_number] => 20030232888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Methods for identifying and using IKK inhibitors' [patent_app_type] => new [patent_app_number] => 10/376470 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19310 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232888.pdf [firstpage_image] =>[orig_patent_app_number] => 10376470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825666 [patent_doc_number] => 20030236288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Use of substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadizol-2-ones for inhibiting pancreatic lipase' [patent_app_type] => new [patent_app_number] => 10/376579 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14020 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236288.pdf [firstpage_image] =>[orig_patent_app_number] => 10376579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020072 [patent_doc_number] => 20050222091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Use of tyrosine kinase inhibitors for treating cns disorders' [patent_app_type] => utility [patent_app_number] => 10/505842 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6450 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222091.pdf [firstpage_image] =>[orig_patent_app_number] => 10505842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172695 [patent_doc_number] => 20050203098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Use of tyrosine kinase inhibitors for treating substance use disorders' [patent_app_type] => utility [patent_app_number] => 10/505899 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4964 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203098.pdf [firstpage_image] =>[orig_patent_app_number] => 10505899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6835287 [patent_doc_number] => 20030162833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Fatty acid treatment for cardiac patients' [patent_app_type] => new [patent_app_number] => 10/371685 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 9666 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20030162833.pdf [firstpage_image] =>[orig_patent_app_number] => 10371685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133454 [patent_doc_number] => 20040043001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Pharmaceutical formulations of antineoplastic agents and processes of making and using the same' [patent_app_type] => new [patent_app_number] => 10/371808 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5755 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043001.pdf [firstpage_image] =>[orig_patent_app_number] => 10371808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527058 [patent_doc_number] => 08043650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Treatment of animal carcasses' [patent_app_type] => utility [patent_app_number] => 10/370798 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11825 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/043/08043650.pdf [firstpage_image] =>[orig_patent_app_number] => 10370798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847495 [patent_doc_number] => 20030166662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Treatment of the insulin resistance syndrome' [patent_app_type] => new [patent_app_number] => 10/368826 [patent_app_country] => US [patent_app_date] => 2003-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14097 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166662.pdf [firstpage_image] =>[orig_patent_app_number] => 10368826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874916 [patent_doc_number] => 20030195213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Compounds, compositions and methods for treating or preventing viral infections and associated diseases' [patent_app_type] => new [patent_app_number] => 10/366796 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13098 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195213.pdf [firstpage_image] =>[orig_patent_app_number] => 10366796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706887 [patent_doc_number] => 20030153621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia' [patent_app_type] => new [patent_app_number] => 10/257010 [patent_app_country] => US [patent_app_date] => 2003-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12644 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153621.pdf [firstpage_image] =>[orig_patent_app_number] => 10257010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874917 [patent_doc_number] => 20030195214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Cancer treatment' [patent_app_type] => new [patent_app_number] => 10/364287 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7562 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195214.pdf [firstpage_image] =>[orig_patent_app_number] => 10364287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829287 [patent_doc_number] => 20030180345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Compositions and methods for inhibiting islet dysfunction and autoimmune disorders' [patent_app_type] => new [patent_app_number] => 10/364127 [patent_app_country] => US [patent_app_date] => 2003-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14441 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180345.pdf [firstpage_image] =>[orig_patent_app_number] => 10364127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6705911 [patent_doc_number] => 20030152645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Aqueous ionic solutions and their uses in particular in ophthlamology' [patent_app_type] => new [patent_app_number] => 10/169284 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2389 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152645.pdf [firstpage_image] =>[orig_patent_app_number] => 10169284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740891 [patent_doc_number] => 20030158260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Novel usage' [patent_app_type] => new [patent_app_number] => 10/348717 [patent_app_country] => US [patent_app_date] => 2003-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7146 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20030158260.pdf [firstpage_image] =>[orig_patent_app_number] => 10348717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706815 [patent_doc_number] => 20030153549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Clavams as protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/182072 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4072 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153549.pdf [firstpage_image] =>[orig_patent_app_number] => 10182072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6697367 [patent_doc_number] => 20030109561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Treatment of diabetes with thiazolidinedione and sulphonylurea' [patent_app_type] => new [patent_app_number] => 10/346947 [patent_app_country] => US [patent_app_date] => 2003-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3482 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0109/20030109561.pdf [firstpage_image] =>[orig_patent_app_number] => 10346947 [rel_patent_id] =>[rel_patent_doc_number] =>)